Global Oligonucleotide Therapeutics Market Analysis & Forecasts 2018-2022, With an Expected CAGR of 9.52% - ResearchAndMarkets.com

DUBLIN--()--The "Global Oligonucleotide Therapeutics Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The analysts forecast the Global Oligonucleotide Therapeutics Market to grow at a CAGR of 9.52% during the period 2018-2022.

Oligonucleotides are short nucleotides sequences of DNA or RNA molecules called oligomers. Oligonucleotide therapeutics target and inhibit the expression of certain diseases-causing genes, thus forming a new class of therapeutics to treat chronic diseases.

The report covers the present scenario and the growth prospects of the oligonucleotide therapeutics market. To calculate the market size, the report considers the revenue generated from the sales of oligonucleotide therapeutics.

One trend affecting this market is the increasing M&A The increasing need to improve technical expertise in oligonucleotide therapeutics have increased M&A. For instance, in February 2018, Takeda pharmaceutical company collaborated with Wave Life Sciences for R&D and multi-program option agreement to develop antisense oligonucleotides for genetically-defined neurological diseases.

One driver influencing this market is the increased availability of approved drugs. Research institutes and pharmaceutical companies make significant investments in RNAi-based drug development to provide advanced treatment options to patients. For instance, Kynamro is a RNAi-based oligonucleotide inhibitor that treats homozygous familial hypercholesterolemia.

The report states that one challenge affecting this market is the inherent challenges with oligonucleotide therapies. The lack of transitional research that can deal with real-world medical and scientific challenges affects the market. Another challenge is due to the administration of RNA-based drugs.

Companies Mentioned

  • Arrowhead Pharmaceuticals
  • GlaxoSmithKline
  • Ionis Pharmaceuticals
  • miRagen Therapeutics
  • Sarepta Therapeutics

Key Topics Covered:

1: Executive Summary

2: Scope Of The Report

3: Research Methodology

4: Market Landscape

5: Market Sizing

6: Five Forces Analysis

7: Market Segmentation By Application

8: Market Segmentation By Technology

9: Customer Landscape

10: Regional Landscape

11: Decision Framework

12: Drivers And Challenges

13: Market Trends

14: Vendor Landscape

15: Vendor Analysis

16: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/wdh9lx/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceuticals

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceuticals